Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Endocrine Reviews · 2024
DOI: 10.1210/endrev/bnae023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, 2024. Verfasst von Niki Karavitaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Analgesics, Opioid, Endocrine System. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 253 Literaturangaben.
Abstract (Originalsprache)
The use and misuse of opioids are a growing global problem. Although the effects of these drugs on the human endocrine system have been studied for decades, attention on their related clinical consequences, particularly on the hypothalamic-pituitary system and bone health, has intensified over recent years. This Statement appraises research data related to the impact of opioids on the gonadal and adrenal function. Whereas hypogonadism is well recognized as a side effect of opioids, the significance of their inhibitory actions on the hypothalamic-pituitary-adrenal system and the occurrence of clinically relevant adrenal insufficiency is not fully elucidated. The often-inconsistent results of studies investigating how opioids affect the secretion of GH, prolactin, arginine vasopressin, and oxytocin are assessed. The accumulating evidence of opioid actions on bone metabolism and their negative sequelae on bone mineral density and risk of fracture are also reviewed. In each section, available data on diagnostic and management approaches for opioid endocrine sequelae are described. This Statement highlights a plethora of gaps in research associated with the effects and clinical consequences of opioids on the endocrine system. It is anticipated that addressing these gaps will improve the care of people using or misusing opioids worldwide. The Statement is not intended to serve as a guideline or dictate treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK.
- Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham B15 2TT, UK.
- Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK.
- Pain Management and Addiction Medicine, Saratoga Hospital Medical Group, Saratoga Springs, NY 12866, USA.
- Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
ORCID-Profile: Niki Karavitaki, Mirjam Christ-Crain, Elena Tsourdi
Zitieren
APA
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024). Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. Endocrine Reviews. https://doi.org/10.1210/endrev/bnae023
Vancouver
Karavitaki N, Bettinger JJ, Biermasz N, Christ-Crain M, Gadelha MR, Inder WJ, et al. Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement. Endocrine Reviews. 2024. doi:10.1210/endrev/bnae023
BibTeX
@article{Karavitaki2024,
author = {Karavitaki, Niki and Bettinger, Jeffrey J and Biermasz, Nienke and Christ-Crain, Mirjam and Gadelha, Monica R and Inder, Warrick J and Tsourdi, Elena and Wakeman, Sarah E and Zatelli, Maria},
title = {Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement},
journal = {Endocrine Reviews},
year = {2024},
doi = {10.1210/endrev/bnae023}
}
EUVIMED